norgestrienone
Sign in to saveNorgestrienone, sold under the brand names Ogyline, Planor, and Miniplanor, is a progestin medication which has been used in birth control pills, sometimes in combination with ethinylestradiol. It was developed by Roussel Uclaf and has been registered for use only in France. Under the brand name Planor, it has been marketed in France as 2 mg norgestrienone and 50 μg ethinylestradiol tablets. It is taken by mouth.
Research
264 papers- Endometriosis.British journal of hospital medicine · 1988
- [Antiprogestins].Zentralblatt fur Gynakologie · 1988
- Endometriosis.Lancet (London, England) · 1993
- Treatment of endometriosis.Lancet (London, England) · 1992
- Endometriosis: medical therapy.Bailliere's clinical obstetrics and gynaecology · 1993
via PubMed
Wikidata facts
- Mass
- 294.162
Show 4 more facts
- chemical formula
- C₂₀H₂₂O₂
- canonical SMILES
- CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(C#C)O
- isomeric SMILES
- C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C#C)O
- Commons category
- Norgestrienone
Sources (2)
via Wikidata · CC0
~4 min read
Article
13 sectionsContents
- Medical uses
- Side effects
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- History
- Society and culture
- Generic names
- Brand names
- Availability
- Research
- References
Norgestrienone, sold under the brand names Ogyline, Planor, and Miniplanor, is a progestin medication which has been used in birth control pills, sometimes in combination with ethinylestradiol. It was developed by Roussel Uclaf and has been registered for use only in France. Under the brand name Planor, it has been marketed in France as 2 mg norgestrienone and 50 μg ethinylestradiol tablets. It is taken by mouth.
Norgestrienone is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like progesterone. It has some androgenic activity.